July 28, 1917


JAMA. 1917;LXIX(4):305-306. doi:10.1001/jama.1917.02590310057020

This article is only available in the PDF format. Download the PDF to view the article, as well as its associated figures and tables.


[Last week we commented on the fact that the Adamson bill had passed the House of Representatives and would, quite likely, soon pass the Senate; that it included a clause authorizing the Federal Trade Commission to grant licenses to citizens of this country to manufacture products controlled, through patents, by enemy aliens. Bearing on this subject is a letter to the Chairman of the Federal Trade Commission, which is of such importance, in that it states concisely certain facts, that we gladly give space to it.—Ed.]

New York, July 19, 1917.

Hon. William J. Harris, Chairman, Federal Trade Commission, Washington, D. C.

Sir:  —In view of the possibility of the enactment of the Adamson bill, providing for the licensing of foreign patents to American citizens, I beg to present a few considerations bearing on the subject of salvarsan. As a former president of the American Dermatological Association, a member

First Page Preview View Large
First page PDF preview
First page PDF preview